Dr. Dulai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
259 E Erie St
Ste 1600
Chicago, IL 60611Phone+1 312-695-5620Fax+1 312-695-2729
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2014
Dayanand Medical College Class of 2009
Certifications & Licensure
NH State Medical License 2013 - Present
IL State Medical License 2021 - 2026
CA State Medical License 2014 - 2023- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Sherman Emerging Leader Prize 2022
Clinical Trials
- Hyperbaric Oxygen for Ulcerative Colitis Start of enrollment: 2013 Aug 01
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Start of enrollment: 2017 Sep 07
Publications & Presentations
PubMed
- Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.Sailish Honap, Vipul Jairath, Bruce E Sands, Parambir S Dulai, Peter Dr Higgins
Clinical Gastroenterology and Hepatology. 2024-12-14 - Correction to: Genetic Risk, Dysbiosis, and Treatment Stratification Using Host Genome and Gut Microbiome in Inflammatory Bowel Disease.Ahmed Moustafa, Weizhong Li, Ericka L Anderson, Emily H MWong, Parambir S Dulai
Clinical and Translational Gastroenterology. 2024-12-10 - Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controll...Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, Guangyong Zou, Laurent Peyrin-Biroulet
Eclinicalmedicine. 2024-12-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis ConceptsParambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
- Join now to see all
Press Mentions
Understanding a Novel Mechanism of Action in Ulcerative ColitisOctober 21st, 2024- Oxygen Therapy Offers Promising Results in People with Crohn’s FistulasFebruary 1st, 2023
- Digbi Health Launches Digbi Digestive™, the First Gut Microbiome and Genetic-Based Digital Care Program to Address IBS and Functional Digestive Disorders Affecting 70M AmericansJune 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
